MHPA applauds efforts by Congress to address drug shortages and ensure that Americans have access to affordable generic drugs. Ensuring that generic, sterile injectable drugs are accessible for use in surgery and in emergency departments and for serious diseases such as cancer is an issue of critical importance for Medicaid enrollees, especially, who rely on the program to treat chronic and acute health conditions.

Read the letter here.